FILE PHOTO: Logo and flags of Bayer AG are pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo
FRANKFURT (Reuters) – A pending U.S. lawsuit over claims related to Bayer’s (BAYGn.DE) glyphosate-based herbicide Roundup has been delayed, the company said on Sunday.
“The Oct. 15, 2019 trial date for Winston v. Monsanto in St. Louis City has been postponed, and the parties will work with the court to determine a new date,” Bayer said in a statement.
The lawsuit is the latest of several to be delayed as mediator Ken Feinberg tries to negotiate a settlement between the company and U.S. plaintiffs after a California jury in August last year found that Monsanto should have warned of alleged cancer risks.
“With the change in the trial schedule and no trial dates set through the rest of the year, the appeals of the three completed trials will be a significant focus of the litigation in the months ahead,” Bayer said.
Handelsblatt first reported the latest delay earlier on Sunday
The number of U.S. plaintiffs blaming Roundup and other glyphosate-based weed killers for cancer has been rising continuously to stand at 18,400 as of July 11, hitting Bayer’s share price.
Reporting by Tina Bellon; Editing by Kirsten Donovan
English 
Azerbaijani